Dallara Que 4

What Happened Dallara Que, CEO of MiniMed Group, Inc. (MMED), was granted a total of 621,563 restricted stock units (RSUs) on 2026-03-11. These grants were not purchases or sales but conversion awards (transaction code A) — Medtronic RSUs held by the reporting person were converted into MMED RSUs as part of MMED’s separation from Medtronic. The filing shows no per-share cash price (N/A) because these are conversion awards, not an open-market trade.

Key Details

• Transaction date: 2026-03-11 (Form 4 filed 2026-03-13 — appears timely).
• Total RSUs granted: 621,563 (six tranches).
• Tranche breakdown and vesting (per filing footnotes):
  • 281,937 RSUs — vest April 30, 2027.
  • 127,609 RSUs — vest April 28, 2028.
  • 57,239 RSUs — vest July 31, 2026.
  • 80,842 RSUs — vest July 29, 2027.
  • 51,044 RSUs — vest July 28, 2028.
  • 22,892 RSUs — vest in two equal installments on March 10, 2026 and March 10, 2027.
• Price/value: N/A on the Form 4 lines; conversion amounts were determined using average Medtronic and MMED closing prices per the Employee Matters Agreement (see footnotes).
• Ownership after transaction: not specified in the excerpt provided.
• Notable footnotes: (F1–F2) awards were converted under the Employee Matters Agreement and an Equity Award Conversion using specified average closing prices; (F3–F9) describe plan (2026 LTIP) and vesting schedules for each tranche.

Context

• These were conversion grants arising from MMED’s separation from Medtronic, not new cash purchases or sales. Converted RSUs are time-vesting equity awards that will convert to shares on their respective vesting dates.
• Because this is an award/conversion (not a sale), it does not directly signal buying or selling sentiment; it reflects the transfer and re-denomination of prior Medtronic awards into MMED equity per separation agreements.
• No 10b5-1 plan, tax withholding, or late-filing flags were indicated in the provided excerpt.